COSMOS Pharmaceutical Corporation (JP:3349) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Cosmos Pharmaceutical Corporation reported an increase in net sales to 964,989 million yen for the fiscal year ended May 31, 2024, a 16.6% rise from the previous year, with a profit attributable to owners of 24,454 million yen, marking a 2.8% increase. The company also announced a dividend of 120.00 yen per share, an uptick from the previous year’s 100.00 yen, with a planned 2-for-1 stock split in September 2024. Looking ahead, Cosmos projects a continuation of growth for the fiscal year ending May 31, 2025, with an anticipated net sales of 1,037,000 million yen.
For further insights into JP:3349 stock, check out TipRanks’ Stock Analysis page.